bispecific antibody treatment in non-hodgkin lymphoma: glofitamab - blood cancers onctalk 2023
Published 6 months ago • 60 plays • Length 2:52Download video MP4
Download video MP3
Similar videos
-
6:06
bispecific antibody treatment in non-hodgkin lymphoma: epcoritamab - blood cancers onctalk 2023
-
2:06
patient role in bispecific antibody treatment - blood cancer onctalk 2023
-
1:37
pros and cons of bispecific antibodies - blood cancer onctalk 2023
-
1:56
types of bispecific antibodies - blood cancer onctalk 2023
-
4:53
immunotherapy treatments b-cell non-hodgkin's: bispecific antibodies - blood cancer video library
-
3:56
bispecific antibodies in myeloma: approvals and clinical trials - blood cancer onctalk 2023
-
2:53
management of bispecific antibodies side effects - blood cancer onctalk 2023
-
5:13
emerging immunotherapy treatments for b-cell non-hodgkin's lymphoma: bispecific antibodies
-
9:15
immunotherapy treatments for b-cell non-hodgkin's lymphoma: car-t cells - blood cancer video library
-
3:44
bispecific antibodies in lung cancer - onctalk lung 2023
-
2:47
efficacy of epcoritamab and glofitamab in diffuse large b-cell lymphoma - blood cancers onctalk 2023
-
2:39
q&a: bispecific treatment in lymphoma: key doctor discussions - blood cancer onctalk 2023
-
1:05
q&a: does bispecific treatment for lymphoma affect fertility? - blood cancer onctalk 2023
-
9:36
emerging immunotherapy treatments for b-cell non-hodgkin's lymphoma: car-t cells
-
4:20
bispecific treatments for multiple myeloma - blood cancers video library
-
3:02
efficacy of epcoritamab and glofitamab in diffuse large b-cell lymphoma